Oliver Cohen

2.6k total citations
22 papers, 291 citations indexed

About

Oliver Cohen is a scholar working on Molecular Biology, Nephrology and Genetics. According to data from OpenAlex, Oliver Cohen has authored 22 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Nephrology and 6 papers in Genetics. Recurrent topics in Oliver Cohen's work include Amyloidosis: Diagnosis, Treatment, Outcomes (19 papers), Parathyroid Disorders and Treatments (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Oliver Cohen is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (19 papers), Parathyroid Disorders and Treatments (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Oliver Cohen collaborates with scholars based in United Kingdom, United States and Japan. Oliver Cohen's co-authors include Ashutosh Wechalekar, Julian D. Gillmore, Helen J. Lachmann, Philip N. Hawkins, Carol Whelan, Marianna Fontana, Shameem Mahmood, Sajitha Sachchithanantham, Darren Foard and Richa Manwani and has published in prestigious journals such as Blood, Annals of the Rheumatic Diseases and Thorax.

In The Last Decade

Oliver Cohen

21 papers receiving 286 citations

Peers

Oliver Cohen
Richa Manwani United Kingdom
Ketna Patel United Kingdom
Cristina Quarta United Kingdom
Karen Wells United States
S. Mahmood United Kingdom
Franco Bergesio Italy
Constantinos Pamboukas Greece
Sébastien Delbès France
Ioanna Dialoupi Greece
Brendan Wisniowski Australia
Richa Manwani United Kingdom
Oliver Cohen
Citations per year, relative to Oliver Cohen Oliver Cohen (= 1×) peers Richa Manwani

Countries citing papers authored by Oliver Cohen

Since Specialization
Citations

This map shows the geographic impact of Oliver Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Cohen more than expected).

Fields of papers citing papers by Oliver Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Cohen. The network helps show where Oliver Cohen may publish in the future.

Co-authorship network of co-authors of Oliver Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Cohen. A scholar is included among the top collaborators of Oliver Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Cohen. Oliver Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lachmann, Helen J., Oliver Cohen, Marianna Fontana, et al.. (2024). OP0323 CAUSES OF AA AMYLOIDOSIS: ANALYSIS OF 952 PATIENTS SEEN AT A REFERENCE CENTRE OVER 34 YEARS. Annals of the Rheumatic Diseases. 83. 8–9. 1 indexed citations
2.
Khwaja, Jahanzaib, Sriram Ravichandran, Oliver Cohen, et al.. (2024). Refining prognostication in systemic AL amyloidosis: limited value of dFLC. Amyloid. 31(4). 353–355. 3 indexed citations
3.
Ravichandran, Sriram, Jahanzaib Khwaja, Oliver Cohen, et al.. (2024). Response rates to second‐line treatment with daratumumab bortezomib dexamethasone (DVD) in relapsed/refractory light chain amyloidosis (AL) after initial Bortezomib‐based regime. British Journal of Haematology. 205(1). 138–145. 1 indexed citations
4.
Khwaja, Jahanzaib, Sriram Ravichandran, Oliver Cohen, et al.. (2023). Limited Utility of Mayo 2012 Cardiac Staging System for Risk Stratification of Patients with Advanced Cardiac AL Amyloidosis - Analysis of a Uniformly Treated Cohort of 1275 Patients. Blood. 142(Supplement 1). 537–537. 5 indexed citations
5.
Cohen, Oliver, Regina Rendas‐Baum, Kristen McCausland, et al.. (2023). Linking changes in quality of life to haematologic response and survival in systemic immunoglobulin light‐chain amyloidosis. British Journal of Haematology. 201(3). 422–431. 3 indexed citations
6.
Cohen, Oliver, Aviva Petrie, Sriram Ravichandran, et al.. (2022). Prognostic importance of the 6 min walk test in light chain (AL) amyloidosis. Heart. 108(20). 1616–1622. 8 indexed citations
7.
8.
Cohen, Oliver, Steven Law, Sriram Ravichandran, et al.. (2022). The experience of hereditary apolipoprotein A-I amyloidosis at the UK National Amyloidosis Centre. Amyloid. 29(4). 237–244. 12 indexed citations
9.
Law, Steven, Aviva Petrie, Liza Chacko, et al.. (2021). Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy. Heart. 108(6). 474–478. 20 indexed citations
10.
Ravichandran, Sriram, Oliver Cohen, Steven Law, et al.. (2021). Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib. Blood Cancer Journal. 11(6). 118–118. 20 indexed citations
11.
Cohen, Oliver, Gavin Manmathan, Anne Riddell, et al.. (2021). Challenges of antithrombotic therapy in the management of cardiovascular disease in patients with inherited bleeding disorders: A single‐centre experience. Haemophilia. 27(3). 425–433. 8 indexed citations
12.
13.
Sharpley, Faye, Richa Manwani, Aviva Petrie, et al.. (2021). Autologous stem cell transplantation vs bortezomib based chemotheraphy for the first‐line treatment of systemic light chain amyloidosis in the UK. European Journal Of Haematology. 106(4). 537–545. 2 indexed citations
14.
Law, Steven, Aviva Petrie, Liza Chacko, et al.. (2020). Disease Progression in Cardiac Transthyretin Amyloidosis is Indicated by Serial Calculation of National Amyloidosis Centre Transthyretin Amyloidosis Stage. ESC Heart Failure. 7(6). 3942–3949. 29 indexed citations
15.
Cohen, Oliver, Shameem Mahmood, Sajitha Sachchithanantham, et al.. (2020). Rapid response to single agent daratumumab is associated with improved progression-free survival in relapsed/refractory AL amyloidosis. Amyloid. 27(3). 200–205. 13 indexed citations
16.
Cohen, Oliver, Faye Sharpley, Janet A. Gilbertson, et al.. (2020). The value of screening biopsies in light‐chain (AL) and transthyretin (ATTR) amyloidosis. European Journal Of Haematology. 105(3). 352–356. 14 indexed citations
17.
Law, Steven, Oliver Cohen, Helen J. Lachmann, et al.. (2020). Renal transplant outcomes in amyloidosis. Nephrology Dialysis Transplantation. 36(2). 355–365. 18 indexed citations
18.
Cohen, Oliver, Sriram Ravichandran, Steven Law, et al.. (2020). The Prognostic Importance of the 6-Minute Walk Test in AL Amyloidosis. Blood. 136(Supplement 1). 16–17. 2 indexed citations
19.
Manwani, Richa, Oliver Cohen, Faye Sharpley, et al.. (2019). A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib. Blood. 134(25). 2271–2280. 115 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richa Manwani Breakdown of academic impact, for papers by Ketna Patel Breakdown of academic impact, for papers by Cristina Quarta Breakdown of academic impact, for papers by Karen Wells Breakdown of academic impact, for papers by S. Mahmood Breakdown of academic impact, for papers by Franco Bergesio Breakdown of academic impact, for papers by Constantinos Pamboukas Breakdown of academic impact, for papers by Sébastien Delbès Breakdown of academic impact, for papers by Ioanna Dialoupi Breakdown of academic impact, for papers by Brendan Wisniowski
Rankless by CCL
2026